Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials

References

• DougadosMBaetenDSpondyloarthritisLancet201137797832127213721684383
   PubMed Web of Science ®Google Scholar
• BraunJSieperJClassification, diagnosis, and referral of patients with axial spondyloarthritisRheum Dis Clin North Am201238347748523083749
   PubMed Web of Science ®Google Scholar
• Van der LindenSValkenburgHACatsAEvaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteriaArthritis Rheum19842743613686231933
   PubMed Web of Science ®Google Scholar
• RudwaleitMvan der HeijdeDLandewéRThe development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selectionAnn Rheum Dis200968677778319297344
   PubMed Web of Science ®Google Scholar
• KiltzUBaraliakosXKarakostasPDo patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?Arthritis Care Res (Hoboken)20126491415142222505331
   PubMed Web of Science ®Google Scholar
• BraunJSieperJAnkylosing spondylitisLancet200736995701379139017448825
   PubMed Web of Science ®Google Scholar
• BoonenAChorusAMiedemaHvan der HeijdeDvan der TempelHvan der LindenSEmployment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patientsAnn Rheum Dis200160435335811247865
   PubMed Web of Science ®Google Scholar
• ZochlingJVan Der HeijdeDBurgos-VargasRASAS/EULAR recommendations for the management of ankylosing spondylitisAnn Rheum Dis200665444245216126791
   PubMed Web of Science ®Google Scholar
• BraunJVan Den BergRBaraliakosX2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisAnn Rheum Dis201170689690421540199
   PubMed Web of Science ®Google Scholar
• ToussirotÉBiologics in spondyloarthritis: TNFα inhibitors and other agentsImmunotherapy20157666968126058432
   PubMed Web of Science ®Google Scholar
• MazumdarSGreenwaldDGolimumabMAbs20091542243120065639
   PubMed Web of Science ®Google Scholar
• GelferGPerryLDeodharAGolimumab for the treatment of axial spondyloarthritisExpert Rev Clin Immunol201612191826523483
   PubMed Web of Science ®Google Scholar
• Simponi : EPAR - European Medicines AgencySummary of Product Characteristics Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000992/WC500052368.pdfAccessed April 1, 2016
   Google Scholar
• Rios RodriguezVPoddubnyyDGolimumab for treatment of axial spondyloarthritisImmunotherapy20168210711526798943
   PubMed Web of Science ®Google Scholar
• InmanRDDavisJCJrHeijdeDEfficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trialArthritis Rheum200858113402341218975305
   PubMed Web of Science ®Google Scholar
• SieperJvan der HeijdeDDougadosMA randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritisArthritis Rheumatol201567102702271226139307
   PubMed Web of Science ®Google Scholar
• BraunJDeodharAInmanRDGolimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE studyAnn Rheum Dis201271566166722012970
   PubMed Web of Science ®Google Scholar
• DeodharABraunJInmanRDGolimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE studyAnn Rheum Dis201574475776125387477
   PubMed Web of Science ®Google Scholar
• CreemersMCFranssenMJvan’t HofMAGribnauFWvan de PutteLBvan RielPLAssessment of outcome in ankylosing spondylitis: an extended radiographic scoring systemAnn Rheum Dis200564112712915051621
   PubMed Web of Science ®Google Scholar
• MaksymowychWPElewautDSchettGMotion for debate: the development of ankylosis in ankylosing spondylitis is largely dependent on inflammationArthritis Rheum20126461713171922354725
   PubMed Web of Science ®Google Scholar
• Van Der HeijdeDLandeweRBaraliakosXRadiographic findings following two years of infliximab therapy in patients with ankylosing spondylitisArthritis Rheum200858103063307018821688
   PubMed Web of Science ®Google Scholar
• Van Der HeijdeDLandeweREinsteinSRadiographic progression of ankylosing spondylitis after up to two years of treatment with etanerceptArthritis Rheum20085851324133118438853
   PubMed Web of Science ®Google Scholar
• Van Der HeijdeDSalonenDWeissmanBNAssessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 yearsArthritis Res Ther2009114R12719703304
   PubMed Web of Science ®Google Scholar
• HaroonNInmanRDLearchTJThe impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitisArthritis Rheum201365102645265423818109
   PubMed Web of Science ®Google Scholar
• BraunJBaraliakosXHermannKGThe effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trialAnn Rheum Dis20147361107111323644549
   PubMed Web of Science ®Google Scholar
• ZochlingJBaraliakosXHermannKGMagnetic resonance imaging in ankylosing spondylitisCurr Opin Rheumatol200719434635217551364
   PubMed Web of Science ®Google Scholar
• BraunJBaraliakosXHermannKGGolimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo-controlled GO-RAISE studyAnn Rheum Dis201271687888422128083
   PubMed Web of Science ®Google Scholar
• BraunJBaraliakosXGolderWMagnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring systemArthritis Rheum20034841126113612687557
   PubMed Web of Science ®Google Scholar
• KirkhamBWWaskoMCHsiaECEffects of golimumab, an anti-tumour necrosis factor-alpha human monoclonal antibody, on lipids and markers of inflammationAnn Rheum Dis201473116116923300117
   PubMed Web of Science ®Google Scholar
• WagnerCVisvanathanSBraunJSerum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumabAnn Rheum Dis201271567468022039165
   PubMed Web of Science ®Google Scholar
• van der HeijdeDDeodharABraunJThe effect of golimumab therapy on disease activity and health-related quality of life in patients with ankylosing spondylitis: 2-year results of the GO-RAISE trial. GO-RAISE investigatorsJ Rheumatol20144161095110324737912
   PubMed Web of Science ®Google Scholar
• van der HeijdeDBraunJDeodharAComparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)Rheumatology (Oxford)201352232132523024015
   PubMed Web of Science ®Google Scholar
• KayJFleischmannRKeystoneEGolimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisAnn Rheum Dis201574353854624344160
   PubMed Web of Science ®Google Scholar
• SchaeverbekeTTruchetetMEKostineMBarnetcheTBannwarthBRichezCImmunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practiceRheumatology (Oxford)201655221022026268816
   PubMed Web of Science ®Google Scholar
• ChenDYChenYMHungWTImmunogenicity, drug trough levels and therapeutic response in patients with rheumatoid arthritis or ankylosing spondylitis after 24-week golimumab treatmentAnn Rheum Dis201574122261226426443609
   PubMed Web of Science ®Google Scholar
• PetersMJDijkmansBANurmohamedMTCardiovascular risk profile of patients with spondyloarthropathies, particularly ankylosing spondylitis and psoriatic arthritisSemin Arthritis Rheum200434358559215609262
   PubMed Web of Science ®Google Scholar
• ToussirotÉEffects of TNFα inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritisExpert Opin Drug Saf201514452553225599626
   PubMed Web of Science ®Google Scholar
• TamLSShangQKunEWThe effects of golimumab on subclinical atherosclerosis and arterial stiffness in ankylosing spondylitis. a randomized, placebo-controlled pilot trialRheumatology (Oxford)20145361065107424501241
   PubMed Web of Science ®Google Scholar
• MokCCLiOCChanKLHoLYHuiPKEffect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trialScand J Rheumatol201544648048626271141
   PubMed Web of Science ®Google Scholar
• ToussirotEWendlingDAntiinflammatory treatment with bisphosphonates in ankylosing spondylitisCurr Opin Rheumatol200719434034517551363
   PubMed Web of Science ®Google Scholar